News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
The Joint AACR-EACR Symposium on Spatial Analysis of Tumours
Photo from AACR/X
Jun 12, 2024, 11:32

The Joint AACR-EACR Symposium on Spatial Analysis of Tumours

AACR (American Association for Cancer Research) shared a post on X/Twitter:

”Today at EACR24, Peter Sorger and AACR Fellows Rene Bernards chaired the Joint AACR-EACR Symposium on ‘Spatial Analysis of Tumours,’ featuring Itay Tirosh, Randi Feist, Bozena Kaminska and Maria Secrier.”

Source: AACR/X

AACR American Association for Cancer Research Bozena Kaminska cancer EACR24 Itay Tirosh Maria Secrier OncoDaily Oncology Peter Sorger Randi Feist Rene Bernards
Blog
Jul 2, 2024, 17:41
Mukhtasar M. Alkali: Governments to prioritize Cervical Cancer Elimination affecting millions of women
Blog
Jul 2, 2024, 17:21
Amalya Sargsyan: One of Oncodaily’s top 10 promising drugs is showing great resuts at ESMOGI24
Blog
Jul 2, 2024, 17:11
Megan-Claire Chase: Serious challenges of 'surviving' breast cancer as a Black woman under 40
Blog
Jul 2, 2024, 16:22
Eric H Yang: Our talented housestaff research achievements
Blog
Jul 2, 2024, 16:08
Nelson Dusetti: Clinic and Digital Personalized Medicine seminar at the University of Corte
Blog
Jul 2, 2024, 16:00
Early registration for ASCOQLTY24 is open
Blog
Jul 2, 2024, 15:29
European Cancer Organisation - Join INTERACT EUROPE100!
Blog
Jul 2, 2024, 15:28
Sarah Louden: 2024 ASCO Direct Puerto Rico is an overwhelming success
Insight
Jul 2, 2024, 15:25
Gut microbiota associated with cancer immunotherapy outcomes
Insight
Jul 2, 2024, 15:20
Vincent Rajkumar’s 2024 update on diagnosis, risk stratification, and treatment of myeloma
Blog
Jul 2, 2024, 15:18
Rami Manochakian: 7 excellent peer-reviewed Lung Cancer articles from ASCO24 Educational Book
Insight
Jul 2, 2024, 15:14
Managing dose reduction without compromising outcomes of HR+ breast cancer